Arslan, A. Et Al. 2023. Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics , vol.15, no.2 .

Arslan, A., YET, B., NEMUTLU, E., AKDAĞ ÇAYLI, Y., EROĞLU, H., & ÖNER, L., (2023). Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics , vol.15, no.2.

Arslan, Aslıhan Et Al. "Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation," Pharmaceutics , vol.15, no.2, 2023

Arslan, Aslıhan Et Al. "Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation." Pharmaceutics , vol.15, no.2, 2023

Arslan, A. Et Al. (2023) . "Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation." Pharmaceutics , vol.15, no.2.

@article{article, author={Aslıhan Arslan Et Al. }, title={Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation}, journal={Pharmaceutics}, year=2023}